1023 - Sequence # 4041 | Pre-Procedure Medications-1023 - Sequence # 4041

Video Transcription

This is the IMPACT Registry October 2023 case scenario, where we will review sequence number 4041, pre-procedure medications.  A 10-day-old female delivered via cesarean section with an APGAR score of 7 out of 9 is transferred for respiratory distress. During the examination, a heart murmur is noted,  and a significant PDA is diagnosed after an echocardiogram is obtained.  The patient continues to exhibit signs of respiratory distress, and the decision is made to administer IV endomethacin.  Pharmacologic treatment is unsuccessful, and the patient presents for PDA closure three days later.  Our question is, how is sequence number 4041 pre-procedure medication coded? Number one, no, or number two, yes.  Please take a few moments to review the documentation prior to determining the best answer.  And the answer is number two, yes. Sequence number 4041 seeks to capture if any pre-procedure medications have been prescribed to the patient between two weeks prior to arrival  at this facility and current procedure.  Question, which pre-procedure medications are selected? Number one, sequence number 4048, antiplatelets only. Number two, sequence 4051, prostaglandins only.  Or number three, both sequence number 4048, antiplatelets, and sequence number 4051, prostaglandins.  Please take a few moments to review the documentation prior to making a decision.  And the answer is number two, prostaglandins, sequence number 4051.  The notes clarify, when a medication has multiple potential uses, code the class that was the primary intended use.  Thank you for viewing the IMPACT Registry Case Scenario for October 2020. We hope you enjoyed this webinar. We hope to see you again in the next webinar. Thank you.  Sequence number 4041, pre-procedure medications.

Video Summary

The video discusses a case scenario from the IMPACT Registry in June 2023. It focuses on a four-year-old male infant with transposition of the great arteries (TGA) and a preexisting patent foramen ovale. The plan is to perform a bedside atrial septostomy to improve systemic perfusion. The video asks if this patient is included in the general submission population, with the options being yes or no. The correct answer is no because the balloon atrial septostomy procedure is only captured if performed during a primary IMPACT procedure. The video concludes by thanking viewers for watching. No credits were mentioned in the video.

Keywords

IMPACT Registry

June 2023

transposition of the great arteries

patent foramen ovale

atrial septostomy